| View |
|
DRP-5880-03
|
Atorvastatin (as calcium)
|
Cholecur
|
10 mg
|
Film-Coated Tablet
|
HMG CoA Reductase Inhibitor
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Renewal
|
12 October 2024
|
09 September 2029
|
| View |
|
DRP-6340-03
|
Atorvastatin (As Calcium)
|
Cholecur
|
20 mg
|
Film-Coated Tablet
|
-
|
Azarias Pharmaceutical Laboratories, Inc.
|
Philippines
|
Initial (CLIDP)(Re-Issuance)
|
02 August 2022
|
11 September 2025
|
| View |
|
DRP-6339-03
|
Atorvastatin (As Calcium)
|
Cholecur
|
40 mg
|
Film-Coated Tablet
|
-
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Initial (CLIDP)(Re-Issuance)
|
02 August 2022
|
11 September 2025
|
| View |
|
DRP-6341-03
|
Atorvastatin (As Calcium)
|
Cholecur
|
80 mg
|
Film-Coated Tablet
|
-
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Initial (CLIDP)(Re-Issuance)
|
02 August 2022
|
11 September 2025
|
| View |
|
DRP-6988-02
|
Multivitamins (see formulation on reverse side)
|
Rapid-B + E
|
Thiamine mononitrate (Vitamin B) Pyridoxine hydrochloride (Vitamin B ) Cyanocobalamin (Vitamin B12) dl-Alpha tocopheryl acetate (Vitamin E)
300 mg 100 mg
1 mg
100 mg
|
Tablet
|
Vitamins
|
Azarias Pharmaceutical Laboratories Inc.,
|
philippines
|
Automatic Renewal
|
01 February 2022
|
02 February 2027
|
| View |
|
DRP-8399-02
|
Amino Acid + Sorbitol
|
Promino 5
|
Formulation: Each 100 mL contains:
Glycine L-Phenylalanine L-Arginine Hydrochloride L-Leucine L-Lysine Hydrochloride L-Valine L-Isoleucine L-Aspartic Acid L-Histidine Hydrochloride L-Threonine
760 mg 533 mg 500 mg 490 mg 430 mg 360 mg 352 mg 250 mg 250 mg 250 mg
L-Methionine L-Alanine L-Proline L-Serine L-Tryptophan L-Glutamic Acid L-Tyrosine L-Cystine Sorbitol
225 mg 200 mg 100 mg 100 mg 90 mg 75 mg 25 mg 10 mg
5 mg
|
Solution for Intravenous Infusion
|
Total Parenteral Nutrition
|
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
|
China
|
Renewal
|
15 February 2024
|
20 March 2029
|
| View |
|
DRP-8399-01
|
Amino Acid + Sorbitol
|
Ultramino
|
Formulation: Each 100 mL contains:
Glycine
760 mg L-Phenylalanine
533 mg L-Arginine Hydrochloride L-Leucine L-Lysine Hydrochloride
430 mg L-Valine
360 mg L-Isoleucine
352 mg L-Aspartic Acid L-Histidine Hydrochloride
250 mg L-Threonine
500 mg 490 mg
L-Methionine L-Alanine L-Proline L-Serine L-Tryptophan L-Glutamic Acid L-Tyrosine L-Cystine Sorbitol
225 mg 200 mg 100 mg 100 mg 90 mg
75 mg
25 mg 10 mg
250 mg
5 mg
250 mg
|
Solution for Intravenous Infusion
|
Total Parenteral Nutrition
|
Shijiazhuang No.4 Pharmaceutical Co., Ltd.
|
China
|
Renewal
|
29 February 2024
|
20 March 2029
|
| View |
|
DRP-7996-02
|
Isosorbide Mononitrate
|
Skydur
|
30 mg
|
Prolonged Release Tablet
|
-
|
Micro Labs Limited
|
India
|
-
|
10 November 2021
|
15 February 2025
|
| View |
|
DRP-8025-04
|
Pregabalin
|
None
|
75 mg
|
Capsule
|
Antiepileptic
|
XL Laboratories Pvt. Ltd.
|
India
|
Automatic Renewal
|
31 December 2022
|
19 November 2028
|
| View |
|
DRP-8024-02
|
Pregabalin
|
None
|
150 mg
|
Capsule
|
Antiepileptic
|
XL Laboratories Pvt. Ltd.
|
India
|
Automatic Renewal
|
31 December 2022
|
19 November 2028
|
| View |
|
DRP-3264-11
|
Paracetamol + Vitamin B + Vitamin B6 +
Vitamin B12
|
Neuropain
|
500 mg/ 50 mg/ 100 mg/ 100 mcg
|
Film-Coated Tablet
|
Analgesic
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
21 May 2022
|
20 May 2027
|
| View |
|
DRP-1646-10
|
Salbutamol (as sulfate) + Guaifenesin
|
Ecobroncho
|
1 mg/50 mg per 5 mL
|
Syrup
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
12 November 2021
|
12 March 2026
|
| View |
|
DRP-8514-04
|
Clopidogrel(As Bisulfate)
|
Clomep
|
75 mg
|
Film-Coated Tablet
|
Antithrombotic Agent(Platelet Aggregation Inhibitor)
|
Mepro Pharmaceutical Private Limited
|
India
|
Renewal
|
20 June 2022
|
22 November 2027
|
| View |
|
DRP-3573-03
|
Cefaclor
|
Zyrcef
|
250 mg/ 5 mL
|
Granules For Suspension
|
Antibacterial (Cephalosporin)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
15 December 2023
|
19 February 2029
|
| View |
|
DRP-8252-06
|
Paracetamol
|
Cetastar
|
1 g/100 mL (1% w/v)
|
Solution for IV Infusion
|
Analgesic/Antipyretic
|
Akums Drugs & Pharmaceuticals Ltd.
|
India
|
Renewal
|
08 November 2021
|
02 October 2028
|
| View |
|
HRP-477
|
Chlorhexidine + Isopropyl Alcohol
|
Steri-Q
|
10 mg/0.61 mL [1%(w/v)/61% (v/v)] per mL
|
Solution
(Star Air Fragrance)
|
-
|
Kohl Industries Corporation
|
Philippines
|
-
|
19 November 2021
|
09 November 2026
|
| View |
|
HRP-476
|
Chlorhexidine
|
None
|
4 g (4% w/v) per 100 mL
|
Solution (Nenuco Fragrance)
|
-
|
Kohl Industries Corporation
|
Philippines
|
-
|
19 November 2021
|
09 November 2026
|
| View |
|
DRP-8951-01
|
Ophenadrine Citrate + Paracetamol
|
Norgesia Forte
|
50mg/650mg
|
Tablet
|
-
|
Adcock Ingram Limited - A Medreich Group of
Company
|
India
|
-
|
12 November 2021
|
09 November 2025
|
| View |
|
DRP-8767-02
|
Levocetirizine Dihydrochloride
|
Velozet
|
2.5 mg/5 mL
|
Syrup (Strawberry-Banana Flavor)
|
-
|
LifeSquare Laboratories Inc.
|
Philippines
|
-
|
12 November 2021
|
13 March 2025
|
| View |
|
THPRP-1
|
Hedera helix (Ivy) Leaf Extract
|
Coffit
|
35 mg/5 mL
|
Syrup (Cherry Flavor)
|
-
|
Bhargava Phytolab PVT. Ltd.
|
India
|
-
|
11 November 2021
|
11 November 2026
|